An inflammatory cytokine signature predicts COVID-19 severity and survivalDiane M. Del Valle, Sacha Gnjatic, Seunghee Kim‐Schulze et al.|Nature Medicine|2020Cited by 2.7k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple MyelomaNoopur Raje, James N. Kochenderfer, Jesús G. Berdeja et al.|New England Journal of Medicine|2019Cited by 1.7k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersAngela Dispenzieri, Pieter Sonneveld, Mario Boccadoro et al.|Leukemia|2008Cited by 808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, J H Lee, Juan José Lahuerta et al.|Leukemia|2011Cited by 721
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Susanna Jacobus et al.|New England Journal of Medicine|2022Cited by 457